Cuorips Inc. (4894.T)
Tokyo · JPY · Healthcare · Biotechnology
¥7,310 (+3.69%) as of
Key statistics
- Market cap
- 64.90B
- EPS (TTM)
- -150.27
- Dividend yield
- 0.00%
- 52-week range
- 3,610.00 – 12,400.00
- Beta
- 0.78
- Revenue (TTM)
- 128M
- Profit margin
- 0.00%
- Volume
- 166.90k
About Cuorips Inc.
Cuorips Inc. engages in the research, development, manufacture, commercialization, and sale of human iPS cell-derived cardiomyocyte sheets in Japan. The company offers cellular and tissue-based, and cell processing products. It also provides contract development and manufacturing, and consulting services. The company was formerly known as Cuore Inc. and changed its name to Cuorips Inc. in June 2017. Cuorips Inc. was incorporated in 2017 and is headquartered in Osaka, Japan.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Osaka, Japan
- Employees
- 51
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.